Exentis Group

Exentis Group is a Swiss technology company specializing in modular, industrial-scale additive manufacturing, particularly through its proprietary 3D additive screen printing platform. This platform is used for GMP-compliant production of pharmaceuticals (oral solid dosage forms/tablets), drug delivery systems, and medical devices. It enables mass production (up to 200 million tablets/year per system) with customizable release profiles, multi-API capability (up to three APIs), and supports personalized and combination therapies. The technology is adopted by CDMOs and pharmaceutical manufacturers for clinical and commercial production, including cold process manufacturing to prevent thermal degradation of APIs. Exentis offers its technology via licensing, system sales, and contract manufacturing models.